U.S. Fertility Market Size to Hit USD 8.69 Billion by 2033

The U.S. fertility market size is poised to grow by USD 8.69 billion by 2033 from USD 5.34 billion in 2023, exhibiting a CAGR of 4.78% during the forecast period 2024 to 2033. 

Key Points

• By offering, the assisted reproductive technology segment dominated the market in 2023.
• By end-user, the fertility clinics segment dominated the U.S. fertility market in 2023 and the segment is observed to sustain the dominance throughout the forecast period.

The U.S. fertility market encompasses a range of services and products aimed at assisting individuals and couples in achieving pregnancy and overcoming fertility challenges. With advancements in reproductive technology and increasing societal acceptance of alternative family-building methods, the fertility market in the U.S. has witnessed significant growth in recent years. This market includes fertility clinics, assisted reproductive technology (ART) procedures, fertility drugs, and other related services.

Get a Sample Report: https://www.precedenceresearch.com/sample/3751

Growth Factors

Several factors contribute to the growth of the U.S. fertility market. Firstly, changing lifestyle patterns such as delayed childbearing due to career pursuits and educational goals have led to an increased demand for fertility treatments. Additionally, advancements in medical technology, including in vitro fertilization (IVF), genetic testing, and egg freezing techniques, have expanded the options available to individuals and couples seeking fertility assistance. Moreover, growing awareness and destigmatization of infertility have encouraged more people to seek help from fertility specialists, further driving market growth.

U.S. Fertility Market Scope

Read More: Pharmaceutical Contract Manufacturing Market Size, Growth Report 2033

Opportunities

The U.S. fertility market presents numerous opportunities for expansion and innovation. One significant opportunity lies in catering to the evolving needs of LGBTQ+ individuals and same-sex couples who seek fertility services to build their families. Providing inclusive and specialized care tailored to their unique requirements can tap into an underserved segment of the market. Furthermore, collaborations between fertility clinics and technology companies to develop user-friendly mobile applications for fertility tracking and telemedicine consultations present another avenue for growth and convenience in accessing fertility services.

Challenges

Despite its growth potential, the U.S. fertility market also faces certain challenges. Affordability remains a significant barrier for many individuals, as fertility treatments can be expensive and may not be covered by insurance plans. This financial burden limits access to care and may result in inequities in fertility treatment outcomes. Additionally, regulatory complexities and ethical considerations surrounding assisted reproductive technologies pose challenges for both providers and patients. Maintaining high standards of care while navigating legal and ethical frameworks requires ongoing attention and adaptation within the industry. Lastly, addressing the emotional and psychological aspects of infertility and fertility treatments remains a challenge, highlighting the need for comprehensive support services within fertility clinics.

U.S. Fertility Market Companies

• Boston IVF Fertility Clinic
• INVO Bioscience
• San Diego Fertility Center
• Celmatix
• FUJIFILM IRVINE SCIENTIFIC
• Carolinas Fertility Institute
• Progyny Inc.
• Cook Medical

Data Sources and Methodology

To gather comprehensive insights on the Global U.S. fertility Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.

We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global U.S. fertility Market.

The most resonating, simple, genuine, and important causes because of which you must decide to buy the U.S. fertility market report exclusively from precedence research

• The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2023 to 2032.

Key Features of the Report:

• Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
• Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
• Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.

Market Segmentation:

By Offering

• Assisted Reproductive Technology
  • IVF
  • Artificial Insemination
  • Surrogacy
  • Others
• Fertility Drugs
  • Gonadotropin
  • Anti-estrogen
  • Others
• Others

By End User

• Fertility Clinics
• Hospitals
• Clinical Research Institutes

Reasons to Consider Purchasing the Report:

• Enhance your market research capabilities by accessing this comprehensive and precise report on the global U.S. fertility market.
• Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
• Benefit from in-depth research and analysis of the latest trends shaping the global U.S. fertility market.
• Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global U.S. fertility market.
• Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
• Discover not only the cutting-edge technological advancements in the global U.S. fertility market but also the strategic plans of industry leaders.

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Fertility Market 

5.1. COVID-19 Landscape: U.S. Fertility Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Fertility Market, By Offering

8.1. U.S. Fertility Market Revenue and Volume, by Offering, 2024-2033

8.1.1. Assisted Reproductive Technology

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Fertility Drugs

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Others

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Fertility Market, By End User

9.1. U.S. Fertility Market Revenue and Volume, by End User, 2024-2033

9.1.1. Fertility Clinics

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Clinical Research Institutes

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Fertility Market, Regional Estimates and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Volume Forecast, by Offering (2021-2033)

10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)

Chapter 11. Company Profiles

11.1. Boston IVF Fertility Clinic

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. INVO Bioscience

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. San Diego Fertility Center

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Celmatix

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. FUJIFILM IRVINE SCIENTIFIC

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Carolinas Fertility Institute

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Progyny Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Cook Medical

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Unlocking Market Insights through Data Excellence

The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.

 

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

Precedence Statistics – Empowering Your Data Insights

 

Contact Us

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com